GlassScriptPhysician profile
Sharon A Heil
NPI 1548212814
$707.88
in general payments reported to CMS, 2019-2025
19 companies · $260 in 2025
The $260 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.52 · 2022: $104 · 2023: $150 · 2024: $182 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $183.28 | 2022-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $60.39 | 2022-2024 | |
| Cranial Technologies, INC | $58.99 | 2022-2024 | Doc Band |
| Collegium Pharmaceutical, INC. | $56.40 | 2025 | Jornay Pm |
| Corium, LLC | $55.62 | 2024-2025 | Azstarys |
| Pfizer INC. | $49.26 | 2022-2025 | |
| Ars Pharmaceuticals Operations, INC. | $36.03 | 2025 | Neffy |
| Soleno Therapeutics, INC. | $23.78 | 2025 | Vykat Xr |
| Astrazeneca Pharmaceuticals LP | $23.06 | 2024 | Flumist Quadrivalent |
| Biomarin Pharmaceutical INC. | $18.75 | 2024 | Voxzogo 1.2mg |
| Sanofi-Aventis U.S. LLC | $18.26 | 2025 | |
| Vertical Pharmaceuticals, LLC | $18.24 | 2025 | Relexxii |
| Ucb, INC. | $18.10 | 2023 | Briviact |
| Sanofi Pasteur INC. | $17.32 | 2024 | |
| Kaleo, INC. | $16.19 | 2024 | Auvi-Q |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $14.61 | 2024 | Immunocap |
| Glaxosmithkline, LLC. | $14.10 | 2023 | Bexsero, Rotarix |
| Neos Therapeutics, LP | $13.98 | 2023 | Adzenys Xr-Odt |
| Sobi, INC | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Heil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.